Figure 4.

Mendelian Randomization studies demonstrate that polymorphism in the IL-6 signaling pathway at rs2228145 and rs7529229 concordantly associate with both lifetime lower levels of hsCRP and lifetime lower risks of coronary heart disease. Adapted from Lancet 2012;379:1214-24 and Lancet 2012;379:1205-13.